DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Healthcare
Updated 1m ago
MDA logo

MedApp S.A.WSE:MDA Stock Report

Market Cap zł42.5m
Updated 1m ago
Share Price
n/a
1Y0%
7D-8.6%
1D-1.2%
Portfolio Value
​
View

MedApp S.A.

WSE:MDA Stock Report

Market Cap: zł42.5m

  • Company Overview
  • Valuation
  • Future Growth
  • Past Performance
  • Financial Health
  • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

MedApp (MDA) Stock Overview

Engages in the development of solutions to support imaging diagnostics and digital medicine in Poland, rest of the European Union, and internationally. More details

MDA fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health3/6
Dividends0/6

Risk Analysis

Highly volatile share price over the past 3 months compared to the Polish market

Profit margins (10.7%) are lower than last year (23.8%)

Does not have meaningful revenue (PLN7M)

Does not have a meaningful market cap (PLN43M)


MDA Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW436,653 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
436,653 investors already sharing narratives
zł
Current Price
zł0.17431.3% overvalued intrinsic discount
%/yr
Decrease
Increase
PastFuture-4m12m2016201920222025202620282031Revenue zł2.1mEarnings zł225.5k
Advanced
View all narratives

MedApp S.A. Competitors

Synektik Spólka Akcyjna

Symbol: WSE:SNT
Market cap: zł2.9b

Airway Medix

Symbol: WSE:AWM
Market cap: zł30.2m

Massmedica

Symbol: WSE:MSM
Market cap: zł13.8m

UCrest Berhad

Symbol: KLSE:UCREST
Market cap: RM 48.3m

Price History & Performance

Summary of share price highs, lows and changes for MedApp
Historical stock prices
Current Share Pricezł0.17
52 Week Highzł0.37
52 Week Lowzł0.068
Beta1.08
1 Month Change-12.37%
3 Month Change-26.09%
1 Year Change1.80%
3 Year Change-60.47%
5 Year Change-82.83%
Change since IPO88.89%

Recent News & Updates

Analysis Article • Feb 04

A Look At The Intrinsic Value Of MedApp S.A. (WSE:MDA)

Key Insights Using the 2 Stage Free Cash Flow to Equity, MedApp fair value estimate is zł0.14 Current share price of...

Recent updates

Analysis Article • Feb 04

A Look At The Intrinsic Value Of MedApp S.A. (WSE:MDA)

Key Insights Using the 2 Stage Free Cash Flow to Equity, MedApp fair value estimate is zł0.14 Current share price of...
Analysis Article • Mar 26

Why Investors Shouldn't Be Surprised By MedApp S.A.'s (WSE:MDA) 26% Share Price Surge

MedApp S.A. ( WSE:MDA ) shareholders are no doubt pleased to see that the share price has bounced 26% in the last...
Analysis Article • Jan 29

Is It Too Late To Consider Buying MedApp S.A. (WSE:MDA)?

MedApp S.A. ( WSE:MDA ), is not the largest company out there, but it received a lot of attention from a substantial...
Analysis Article • Mar 12

Can You Imagine How Jubilant MedApp's (WSE:MDA) Shareholders Feel About Its 292% Share Price Gain?

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...
Analysis Article • Jan 18

MedApp S.A.'s (WSE:MDA) Stock Is Going Strong: Have Financials A Role To Play?

Most readers would already be aware that MedApp's (WSE:MDA) stock increased significantly by 16% over the past month...
Analysis Article • Nov 26

Announcing: MedApp (WSE:MDA) Stock Soared An Exciting 363% In The Last Five Years

MedApp S.A. (WSE:MDA) shareholders might understandably be very concerned that the share price has dropped 39% in the...

Shareholder Returns

MDAPL Healthcare ServicesPL Market
7D0%-0.9%2.2%
1Y1.8%-14.1%39.6%

Return vs Industry: MDA exceeded the Polish Healthcare Services industry which returned -12.9% over the past year.

Return vs Market: MDA underperformed the Polish Market which returned 39.2% over the past year.

Price Volatility

Is MDA's price volatile compared to industry and market?
MDA volatility
MDA Average Weekly Movement11.9%
Healthcare Services Industry Average Movement5.5%
Market Average Movement4.6%
10% most volatile stocks in PL Market9.3%
10% least volatile stocks in PL Market2.8%

Stable Share Price: MDA's share price has been volatile over the past 3 months compared to the Polish market.

Volatility Over Time: MDA's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Polish stocks.

About the Company

FoundedEmployeesCEOWebsite
201015David Odrakiewiczmedapp.pl

MedApp S.A. engages in the development of solutions to support imaging diagnostics and digital medicine in Poland, rest of the European Union, and internationally. The company offers CarnaLife Holo, a technology for 3D visualization of imaged medical data which supports the planning and performance of medical procedures. HoloComm, an innovative solution for easy and convenient work on files in 3D.

MedApp S.A. Fundamentals Summary

How do MedApp's earnings and revenue compare to its market cap?
MDA fundamental statistics
Market capzł42.52m
Earnings (TTM)zł724.00k
Revenue (TTM)zł6.77m
58.7x
P/E Ratio
6.3x
P/S Ratio

Is MDA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MDA income statement (TTM)
Revenuezł6.77m
Cost of Revenuezł2.40m
Gross Profitzł4.38m
Other Expenseszł3.65m
Earningszł724.00k

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

Nov 13, 2026

Earnings per share (EPS)0.0029
Gross Margin64.61%
Net Profit Margin10.69%
Debt/Equity Ratio6.5%

How did MDA perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/10 16:47
End of Day Share Price 2026/09/10 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MedApp S.A. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Adrian KowollikEast Value Research GmbH

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide